Citation: | BAI Rong-yu, YI Huan, QIU Jing-wen, CHEN Feng-lian, WANG Ying, CHEN Bing-ying, LI Yu, ZHANG Lei. Effects of Ilex Pubescens Triterpenoid Saponins on Fecal and Urine Metabolomics in Atherosclerotic Rats[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(5): 424-431. doi: 10.14148/j.issn.1672-0482.2022.0424 |
[1] |
MOORE KJ, KOPLEV S, FISHER EA, et al. Macrophage trafficking, inflammatory resolution, and genomics in atherosclerosis: JACC macrophage in CVD series (part 2)[J]. J Am Coll Cardiol, 2018, 72(18): 2181-2197. doi: 10.1016/j.jacc.2018.08.2147
|
[2] |
梅丽, 牛瑞娟, 蒋玲, 等. 毛冬青化学成分及药理活性研究进展[J]. 生物化工, 2018, 4(2): 129-131. doi: 10.3969/j.issn.2096-0387.2018.02.037
MEI L, NIU RJ, JIANG L, et al. Advances in the study on the chemical constituents and pharmacological activities of Ilex pubescens hook. et arn[J]. Biol Chem Eng, 2018, 4(2): 129-131. doi: 10.3969/j.issn.2096-0387.2018.02.037
|
[3] |
ZHOU Y, ZENG KW, ZHANG JY, et al. Triterpene saponins from the roots of Ilex pubescens[J]. Fitoterapia, 2014, 97: 98-104. doi: 10.1016/j.fitote.2014.05.020
|
[4] |
李美芬. 毛冬青中乌苏烷型三萜皂苷的药物代谢研究[D]. 广州: 广州中医药大学, 2011.
LI MF. Study on drug metabolism of ursane-type saponins from Radix ilicis[D]. Guangzhou: Guangzhou University of Chinese Medicine, 2011.
|
[5] |
钟海森, 覃骊兰, 杜正彩, 等. 壮药毛冬青的应用概况[J]. 河北中医, 2018, 40(5): 793-797. doi: 10.3969/j.issn.1002-2619.2018.05.036
ZHONG HS, QIN LL, DU ZC, et al. Overview of the application of the Zhuang medicine Ilex pubescens[J]. Hebei J Tradit Chin Med, 2018, 40(5): 793-797. doi: 10.3969/j.issn.1002-2619.2018.05.036
|
[6] |
白荣钰, 易欢, 陈丰连, 等. 毛冬青三萜皂苷对动脉粥样硬化大鼠肠道菌群的影响[J]. 中草药, 2021, 52(20): 6245-6253. doi: 10.7501/j.issn.0253-2670.2021.20.014
BAI RY, YI H, CHEN FL, et al. Effect of triterpenoid saponins from Ilex pubescens on intestinal flora in atherosclerotic rats[J]. Chin Tradit Herb Drugs, 2021, 52(20): 6245-6253. doi: 10.7501/j.issn.0253-2670.2021.20.014
|
[7] |
陈钰泉, 刘玉婷, 邱杰, 等. 不同比色法测定植物源总三萜皂苷含量的对比[J]. 黑龙江农业科学, 2018(3): 108-112. https://www.cnki.com.cn/Article/CJFDTOTAL-HLJN201803027.htm
CHEN YQ, LIU YT, QIU J, et al. Comparation of different colorimetry for determination of the total herbal triterpenoid saponins[J]. Heilongjiang Agric Sci, 2018(3): 108-112. https://www.cnki.com.cn/Article/CJFDTOTAL-HLJN201803027.htm
|
[8] |
XIAO CN, HAO FH, QIN XR, et al. An optimized buffer system for NMR-based urinary metabonomics with effective pH control, chemical shift consistency and dilution minimization[J]. Analyst, 2009, 134(5): 916-925. doi: 10.1039/b818802e
|
[9] |
WOJTOWICZ W, ZABEK A, DEJA S, et al. Serum and urine 1H NMR-based metabolomics in the diagnosis of selected thyroid diseases[J]. Sci Rep, 2017, 7(1): 9108. doi: 10.1038/s41598-017-09203-3
|
[10] |
刘卫红, 张琪, 颜贤忠, 等. 高脂血症及动脉粥样硬化痰瘀演变的代谢组学研究[J]. 中医杂志, 2008, 49(8): 738-741. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ200808043.htm
LIU WH, ZHANG Q, YAN XZ, et al. Metabonomics study on phlegm and blood stasis evolution of hyperlipidemia and atherosclerosis[J]. J Tradit Chin Med, 2008, 49(8): 738-741. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ200808043.htm
|
[11] |
KUSHIYAMA A, NAKATSU Y, MATSUNAGA Y, et al. Role of uric acid metabolism-related inflammation in the pathogenesis of metabolic syndrome components such as atherosclerosis and nonalcoholic steatohepatitis[J]. Mediators Inflamm, 2016, 2016: 8603164.
|
[12] |
CORRY DB, ESLAMI P, YAMAMOTO K, et al. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system[J]. J Hypertens, 2008, 26(2): 269-275. doi: 10.1097/HJH.0b013e3282f240bf
|
[13] |
庞博, 越晧, 王恩鹏, 等. 动脉粥样硬化患者尿液的代谢组学研究[J]. 分析化学, 2015, 43(11): 1766-1771. doi: 10.11895/j.issn.0253-3820.150434
PANG B, YUE H, WANG EP, et al. A metabonomics study of atherosclerosis by rapid resolution liquid chromatography quadrupole time-of-flight mass spectrometry[J]. Chin J Anal Chem, 2015, 43(11): 1766-1771. doi: 10.11895/j.issn.0253-3820.150434
|
[14] |
PEDERSEN ER, MIDTTUN O, UELAND PM, et al. Systemic markers of interferon-γ-mediated immune activation and long-term prognosis in patients with stable coronary artery disease[J]. Arterioscler Thromb Vasc Biol, 2011, 31(3): 698-704. doi: 10.1161/ATVBAHA.110.219329
|
[15] |
BROWN JM, HAZEN SL. The gut microbial endocrine organ: Bacterially derived signals driving cardiometabolic diseases[J]. Annu Rev Med, 2015, 66: 343-359. doi: 10.1146/annurev-med-060513-093205
|
[16] |
WANG ZN, ROBERTS AB, BUFFA JA, et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis[J]. Cell, 2015, 163(7): 1585-1595. doi: 10.1016/j.cell.2015.11.055
|
[17] |
KOETH RA, LEVISON BS, CULLEY MK, et al. γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO[J]. Cell Metab, 2014, 20(5): 799-812. doi: 10.1016/j.cmet.2014.10.006
|
[18] |
AGUILAR EC, DA SILVA JF, NAVIA-PELAEZ JM, et al. Sodium butyrate modulates adipocyte expansion, adipogenesis, and insulin receptor signaling by upregulation of PPAR-γ in obese Apo E knockout mice[J]. Nutrition, 2018, 47: 75-82. doi: 10.1016/j.nut.2017.10.007
|